简介:【摘要】 目的:分析血液生化检验标本分析中影响检验结果准确性的相关因素。方法:以 165 份血液生化检验标本为研究对象,采集时间 2017 年 1 月~ 2018 年 4 月,回顾性分析相关的检验资料,统计不合格标本数量,分析影响检验结果准确的原因。结果:经统计,在 165 份血液生化检验标本中,不合格检验标本共 19 份,不合格率 11.5% 。分析影响因素发现,占据首位的为采集方法不当,共 10 份,占 52.7% ;其后依次为抗凝剂与血量比例不合理( 7 份, 36.8% )、血液标本保存不当( 2 份, 10.5% )。结论:临床开展血液生化检验标本分析工作时,多种因素会对结果准确性产生影响,检验人员应格外重视这些因素,积极预防及干预,提高检验结果的准确性。
简介:【摘要】目的 评估益气聪明汤治疗椎-基底动脉供血不足性眩晕的临床疗效。方法 计算机检索中文数据库 (中国知网、万方、维普、CBM)和外文数据库(PubMed,Embase,Cochrane Library),查找益气聪明汤治疗椎-基底动脉供血不足性眩晕的随机对照临床试验,根据纳入排除标准进行筛选,确定纳入的文献,进行数据提取。采用 Cochrane 的偏倚风险表评估研究质量,使用 RevMan5.3进行统计分析。结果 共纳入文献6篇,458例患者。Meta分析结果显示,与单纯西医常规治疗相比,加用益气聪明汤治疗椎-基底动脉供血不足性眩晕可降低患者血浆粘度、血细胞比容;同时可提高患者的临床治疗有效率、左椎动脉血流速度、右椎动脉血流速度、基底动脉血流速度。试验序贯分析显示临床疗效累计纳入的研究穿过了传统界值和 TSA 界值,进一步肯定了其临床疗效。结论 与单纯西医常规治疗相比,加用益气聪明汤治疗椎-基底动脉供血不足性眩晕可能具有较好的临床疗效。但文献质量有待提高,故需要高质量的随机对照试验来论证。
简介: 【摘 要】目的:对于门静脉高压性上消化道出血病人采取生长抑素联合小剂量垂体后叶素进行治疗的具体方法以及治疗效果施行分析与总结。方法:将我们医院在 2018年 3月至 2020年 3月所接诊的门静脉高压性上消化道出血病人资料 60例施行分析,所选 60例门静脉高压性上消化道出血病人采取数字法加以分组,给予对照组门静脉高压性上消化道出血病人小剂量垂体后叶素进行治疗,研究组进行门静脉高压性上消化道出血病人生长抑素联合小剂量垂体后叶素治疗,对比两组门静脉高压性上消化道出血病人的止血时间和止血有效率。结果:两组门静脉高压性上消化道出血病人接受治疗之后的止血时间以及止血有效率比较差异明显。结论:临床中针对门静脉高压性上消化道出血病人,为其提供生长抑素联合小剂量垂体后叶素进行治疗效果理想,应该给予大力的推广与应用。 【关键词】门静脉高压性上消化道出血;生长抑素;小剂量垂体后叶素;治疗效果 [Abstract] Objective: to analyze and summarize the specific methods and therapeutic effects of somatostatin combined with low-dose Pituitrin in patients with portal hypertensive upper gastrointestinal hemorrhage. Methods: the data of 60 patients with portal hypertensive upper gastrointestinal bleeding in our hospital from March 2018 to March 2020 were analyzed. 60 patients with portal hypertensive upper gastrointestinal bleeding were divided into groups by digital method To compare the hemostasis time and efficiency of two groups of patients with upper gastrointestinal hemorrhage caused by portal hypertension. Results: there were significant differences in hemostasis time and efficiency between the two groups. Conclusion: in the clinical treatment of patients with portal hypertensive upper gastrointestinal hemorrhage, the effect of somatostatin combined with low dose pituitrin is ideal, which should be vigorously promoted and applied.
简介: 【摘要】 目的:分析复方甘草酸苷联合还原型谷胱甘肽对酒精性肝硬化患者肝功能的影响效果。方法:选择笔者所在医院 2017年 1月 -2019年 12月收治 198例酒精性肝硬化患者,随机分成两组,对照组 99例使用还原型谷胱甘肽治疗,研究组 99例在对照组基础上增加使用复方甘草酸苷治疗,对两组患者肝功能及肝纤维化指标进行比较。结果:研究组患者治疗后 AST、 ALT、 GGT、 TBIL指标均低于对照组,差异均有统计学意义( P<0.05) ;研究组患者治疗后 PCⅢ、 IV-C、 HA指标分别为( 102.78±29.87)、( 62.60±14.41)、( 77.40±20.04) μg/L,各项指标均低于对照组,差异均有统计学意义( P<0.05)。结论:复方甘草酸苷联合还原型谷胱甘肽治疗酒精性肝硬化患者,可改善患者肝功能及肝纤维化指标,能有效促进临床症状好转,临床上值得推广使用。 【关键词】 复方甘草酸苷 ; 还原型谷胱甘肽 ; 酒精性肝硬化 ; 肝功能 [Abstract] Objective: to analyze the effect of Compound Glycyrrhizin Combined with reduced glutathione on liver function in patients with alcoholic cirrhosis. Methods: 198 patients with alcoholic cirrhosis were randomly divided into two groups: the control group (99 cases) were treated with reduced glutathione and the study group (99 cases) were treated with Compound Glycyrrhizin on the basis of the control group. The liver function and liver fibrosis indexes of the two groups were compared. Results: after treatment, AST, alt, GGT and TBIL in the study group were lower than those in the control group (P < 0.05), while PC Ⅲ, IV-C and HA in the study group were (102.78 ± 29.87), (62.60 ± 14.41), (77.40 ± 20.04) μ g / L, respectively, and all indexes were lower than those in the control group (P < 0.05). Conclusion: Compound Glycyrrhizin Combined with reduced glutathione in the treatment of alcoholic liver cirrhosis can improve the liver function and liver fibrosis index, and can effectively promote the improvement of clinical symptoms, which is worth popularizing in clinical.